Jennifer Cochran
InvestorCo-Founder and Chief Scientific Advisor at Red Tree Venture
Stanford / Bay Area
Find your path to Jennifer
29 people in our graph share verified history with Jennifer — schools, employers, funds. One of them is your warm intro.
About
Co-founder and Chief Scientific Advisor of Red Tree and a Stanford bioengineering professor who chaired the department from 2017-2022. A serial entrepreneur who founded companies including xCella Biosciences and Combangio, she holds a Ph.D. in Biological Chemistry from MIT. Also serves as Scientific Advisory Board Chair (Oncology).
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
Biograph 55Biograph55EBVioExcellergy TherapeuticsKivu BioscienceOmniAbRevel PharmaceuticalsRondo Therapeutics
Investor
CombangioPhotinia BiosciencesThreefold TherapeuticsTwoStep TherapeuticsxCella Biosciences
Per the firm's website.
Colleagues at Red Tree Venture
Frequently asked questions
- Who is Jennifer Cochran?
- Co-founder and Chief Scientific Advisor of Red Tree and a Stanford bioengineering professor who chaired the department from 2017-2022. A serial entrepreneur who founded companies including xCella Biosciences and Combangio, she holds a Ph.D. in Biological Chemistry from MIT. Also serves as Scientific Advisory Board Chair (Oncology).
- Where does Jennifer Cochran work?
- Jennifer Cochran is Co-Founder and Chief Scientific Advisor at Red Tree Venture.
- What does Jennifer Cochran invest in?
- Jennifer Cochran invests in Biotech.
- What boards does Jennifer Cochran sit on?
- Jennifer Cochran holds tracked board seats at Biograph 55, Biograph55, EBVio, Excellergy Therapeutics, Kivu Bioscience, OmniAb, Revel Pharmaceuticals, Rondo Therapeutics.
- What companies has Jennifer Cochran invested in?
- Investments tracked here include Combangio, Photinia Biosciences, Threefold Therapeutics, TwoStep Therapeutics, xCella Biosciences.